Q3 2025 Holdings
Filed 2025-11-14 | 73 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | DEBT 1.250% 2/1 | 40131MAD1 | $286.3M | $219,454,000 | 8.5% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $221.3M | 7,316,142 | 6.6% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $210.0M | $211,364,000 | 6.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $144.7M | 3,605,029 | 4.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $132.3M | 3,283,317 | 3.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $123.6M | 880,282 | 3.7% |
| Repligen Corp | NOTE 1.000%12/1 | 759916AD1 | $101.8M | $101,000,000 | 3.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $91.9M | 520,401 | 2.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $87.6M | 1,012,982 | 2.6% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $86.8M | $100,381,000 | 2.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $86.7M | 1,281,989 | 2.6% |
| Irhythm Technologies Inc | NOTE 1.500% 9/0 | 450056AB2 | $85.4M | $62,000,000 | 2.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $84.5M | 5,210,831 | 2.5% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $72.9M | $82,140,000 | 2.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $65.6M | 883,747 | 1.9% |
| Glaukos Corp(GKOS) | COM | 377322102 | $63.6M | 780,164 | 1.9% |
| Danaher Corporation(DHR) | COM | 235851102 | $61.3M | 309,339 | 1.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $59.6M | 1,826,155 | 1.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $58.2M | 130,227 | 1.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $57.2M | 1,438,745 | 1.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $56.1M | 76,091 | 1.7% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $55.3M | 113,933 | 1.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $51.3M | 409,691 | 1.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $50.8M | 2,378,655 | 1.5% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $44.7M | 910,476 | 1.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $43.2M | 2,578,404 | 1.3% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $39.4M | 351,248 | 1.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $38.8M | 225,845 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $35.9M | 141,528 | 1.1% |
| Karyopharm Therapeutics Inc | NOTE 6.000% 5/1 | 48576UAD8 | $35.0M | $48,482,000 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $34.5M | 2,730,481 | 1.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $33.1M | 438,600 | 1.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $32.9M | 835,057 | 1.0% |
| Caredx Inc(CDNA) | COM | 14167L103 | $31.7M | 2,182,781 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.6M | 528,000 | 0.8% |
| Globus MED Inc(GMED) | CL A | 379577208 | $28.5M | 498,000 | 0.8% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $26.6M | 1,382,350 | 0.8% |
| Repligen Corp(RGEN) | COM | 759916109 | $26.2M | 195,656 | 0.8% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $25.0M | 643,180 | 0.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $24.7M | 121,700 | 0.7% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $24.0M | 8,353,287 | 0.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $22.7M | 414,600 | 0.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $22.6M | 475,400 | 0.7% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $22.0M | 1,514,604 | 0.7% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $20.5M | 1,107,770 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $20.0M | 759,455 | 0.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $18.7M | 822,735 | 0.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $18.4M | 303,685 | 0.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $17.7M | 588,700 | 0.5% |
| Harrow Inc(HROW) | COM | 415858109 | $16.5M | 342,391 | 0.5% |